Fig. 1: Overview of the study and the pan-cancer proteomic cohort.
From: Pan-cancer proteogenomic investigations identify post-transcriptional kinase targets
a Study overview for identifying kinase therapeutic targets, combining analyses of aberrant proteins in MS proteomic data of primary tumors, cancer-cell dependencies, and immunohistochemistry evidence. b Distribution of quantified kinases across the global MS proteomic cohorts. c Summary of the sample characteristics for the ten MS global proteomic cohorts totaling 1071 cases.
